Fluorescence immunostaining for the CAF marker αSMA and the M2 macrophage marker CD163 was performed for all resected tumors to quantify αSMA-positive areas and numbers of CD163-positive cells in the tumor area (Figure 3a). The gene discussed is ACTA1; the disease is neoplasm.